Brief: Ironwood Pharmaceuticals Reports Third Quarter 2024 Results
07/11/2024 12:51
Nov 7 (Reuters) - Ironwood Pharmaceuticals Inc IRWD.O :
* IRONWOOD PHARMACEUTICALS REPORTS THIRD QUARTER 2024
RESULTS
* IRONWOOD PHARMACEUTICALS INC: MAINTAINS FULL YEAR 2024
FINANCIAL
GUIDANCE
Source text: ID:nBw5F31cka
Further company coverage: IRWD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ironwood Pharmaceuticals
See all newsBrief: Ironwood Pharmaceuticals Appoints Tammi Gaskins As Chief Executive Officer
Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ironwood Q2 revenue rises 33%
Brief: Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026
Brief: FDA Approves Use Of Linzess In Pediatric Patients Aged 2 & Older With Functional Constipation